title: Percutaneous tibial nerve stimulation and sacral neuromodulation: an update.
abstract: Neuromodulation is an important treatment modality for a variety of pelvic floor disorders. Percutaneous tibial nerve stimulation (PTNS) and sacral neuromodulation (SNM) are currently the two approved methods for delivering this therapy. Percutaneous tibial nerve stimulation is a minimally invasive office-based procedure that has shown efficacy in the treatment of overactive bladder, fecal incontinence, and pelvic pain. It has the advantage of minimal side effects but is limited by the need for patients to make weekly office visits to receive the series of treatments. Sacral neuromodulation uses an implanted device that stimulates the S3 nerve root and can improve symptoms of overactive bladder, non-obstructive urinary retention, fecal incontinence, and pelvic pain. This paper will review the most recent literature regarding this topic and discuss their advantages and limitations and recent innovations in their use.
authors: Female Pelvic Medicine and Reconstructive Surgery, Beaumont Health System, 3535 W. 13 Mile Road, Ste. 438, Royal Oak, MI, 48073, USA, Priyanka.Gupta@beaumont.edu.
authors: Priyanka
authors: P
authors: Gupta
authors: Michael J
authors: MJ
authors: Ehlert
authors: Larry T
authors: LT
authors: Sirls
authors: Kenneth M
authors: KM
authors: Peters
mesh_terms: D004599:Electric Stimulation Therapy / Q000379:methods*; D006801:Humans; D059952:Pelvic Floor Disorders / Q000628:therapy*; D013979:Tibial Nerve
references: Neurourol Urodyn. 2010;29 Suppl 1:S18-23
references: 20419795
references: Female Pelvic Med Reconstr Surg. 2010 Jul;16(4):249-53
references: 22453352
references: Female Pelvic Med Reconstr Surg. 2012 Mar-Apr;18(2):103-12
references: 22453321
references: Am J Surg. 2014 May;207(5):735-7; discussion 737-88
references: 24791636
references: J Urol. 2013 Jan;189(1):210-6
references: 23174264
references: Am J Manag Care. 2009 Mar;15(4 Suppl):S118-22
references: 19355801
references: Female Pelvic Med Reconstr Surg. 2013 Nov-Dec;19(6):322-7
references: 24165444
references: Neurourol Urodyn. 2007;26(1):19-28; discussion 36
references: 17078071
references: Neurourol Urodyn. 2011 Sep;30(7):1249-52
references: 21404317
references: J Urol. 2010 Nov;184(5):2001-6
references: 20850833
references: Obstet Gynecol. 2008 Dec;112(6):1311-8
references: 19037041
references: Urologia. 2012 Dec 30;79 Suppl 19:86-90
references: 22729604
references: J Urol. 2010 Jan;183(1):234-40
references: 19913821
references: Obstet Gynecol. 2014 Jan;123(1):141-8
references: 24463674
references: J Urol. 2010 Apr;183(4):1438-43
references: 20171677
references: Neurourol Urodyn. 2010;29(1):4-20
references: 19941278
references: J Urol. 2013 Jun;189(6):2194-201
references: 23219541
references: J Urol. 2007 Nov;178(5):2029-34
references: 17869298
references: J Urol. 2001 Sep;166(3):914-8
references: 11490245
references: J Urol. 1996 Jun;155(6):2005-11
references: 8618309
references: J Urol. 1989 Aug;142(2 Pt 1):340-5
references: 2787411
references: Urol Int. 2009;83(1):33-8
references: 19641356
references: J Urol. 2010 Nov;184(5):1997-2000
references: 20850820
references: Qual Life Res. 1998 Jan;7(1):57-65
references: 9481151
references: Gynecol Obstet Invest. 2013;75(4):230-4
references: 23548260
references: Urol Clin North Am. 2005 Feb;32(1):71-8, vii
references: 15698879
references: J Urol. 2012 Jan;187(1):178-84
references: 22100006
references: BJU Int. 2014 May;113(5):789-94
references: 24238278
references: J Urol. 2009 Sep;182(3):1055-61
references: 19616802
references: Br J Surg. 2014 Apr;101(5):457-68
references: 24446127
references: J Urol. 2012 Dec;188(6 Suppl):2455-63
references: 23098785
references: Neuromodulation. 2014 Jan;17(1):72-4; discussion 74
references: 23647745
references: J Urol. 2011 Aug;186(2):387-93
references: 21683381
references: Urology. 2014 Oct;84(4):911-7
references: 25096339